An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes

Inclusion Criteria: * Patients with Type 2 diabetes mellitus and a diagnosis of NASH Exclusion Criteria: * Excessive alcohol use * Presence of Type 1 diabetes mellitus * Other chronic liver disease * Previous or current hepatocellular carcinoma * Use of medication known to cause steatosis * Previous bariatric surgery * Pregnancy or breastfeeding * Presence of any severe medical or psychological condition that, in the opinion of the investigator, would compromise the patient's safe participation including uncontrolled serious psychiatric illness such a major depression within the last 2 years, and history of other severe psychiatric disorders The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.